BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa
2012-07-07
(Press-News.org) BOSTON, MA—Researchers at Brigham and Women's Hospital (BWH) have discovered a new vaccine candidate for the bacterium Pseudomonas aeruginosa taking advantage of a new mechanism of immunity.
The study was published online in the American Journal of Respiratory and Critical Care Medicine on June 21, 2012.
Pseudomonas aeruginosa is a leading cause of hospital-acquired infections, particularly in patients on respirators, where it can cause so-called ventilator-associated pneumonia, which carries a very high mortality rate. Pseudomonas also causes lung infections in people with cystic fibrosis, a genetic disorder that renders the lungs susceptible to bacterial infection.
Despite more than 40 years of vaccine research and development, there is no clinically available vaccine for this bacterium. Most prior vaccine efforts have focused on generating antibodies to Pseudomonas toxins or surface molecules, especially the sugar coating on the bug called the lipopolysaccharide O antigen. These approaches have not yielded a licensed vaccine for humans.
Gregory Priebe, MD, BWH Division of Infectious Diseases, Department of Medicine, and Boston Children's Hospital Division of Critical Care Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, along with researchers from Harvard Medical School, constructed a vaccine based on a new mechanism of immunity to Pseudomonas mediated by T helper 17 (Th17) cells. Th17 cells are a recently described type of helper T cells that secrete the cytokine IL-17 and enhance antibacterial mucosal defenses.
In the current studies, the investigators designed a screen for Th17-stimulating protein antigens expressed by a molecular library of DNA encoding Pseudomonas proteins. The screen discovered that the Pseudomonas protein PopB is a very effective stimulator of Th17 immunity, and immunization with purified PopB protected mice from lethal pneumonia in an antibody-independent fashion.
The researchers are currently taking their work a step further by constructing conjugate vaccines using PopB as a protein carrier with the hopes of improving the effectiveness of the vaccine. They hope that the PopB-based vaccine might one day be used to prevent Pseudomonas infections in hospitalized patients and in people with cystic fibrosis.
###
This research was supported by grants from the National Institutes of Health (HL092515).
Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies, OurGenes and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-07-07
Bethesda, MD—In what could be a breakthrough in the practical application of epigenetic science, U.K. scientists used human tissue samples to discover that those with osteoarthritis have a signature epigenetic change (DNA methylation) responsible for switching on and off a gene that produces a destructive enzyme called MMP13. This enzyme is known to play a role in the destruction of joint cartilage, making MMP13 and the epigenetic changes that lead to its increased levels, prime targets for osteoarthritis drug development. In addition to offering a new epigenetic path toward ...
2012-07-07
NEW YORK, July 6, 2012 -- Ben-Gurion University of the Negev (BGU) undergraduate students have developed a new privacy solution for Facebook. The Social Privacy Protector (SPP) can help parents adjust their children's profiles in one click, prevent criminals from garnering valuable personal information and keep teens safe from pedophiles.
The SPP "app" has multiple levels of protection, but the most important component reviews a user's friends list in seconds to identify which have few or no mutual links and might be "fake" profiles. The app analyzes each friend and ...
2012-07-07
Bethesda, MD—Whether from surgery or battle wounds, ugly scars can affect body and mind. Now a new research report appearing online in the FASEB Journal offers a new strategy to reduce or eliminate scars on the skin. Specifically, scientists from NYU describe how agents that block receptors for adenosine (a molecule generated from ATP which is used by the body to provide energy to muscles) can be applied topically to healing wounds to reduce scar size, yielding skin that feels more like the original, unscarred skin.
"Scars can be disfiguring and, if extensive enough, ...
2012-07-07
VIDEO:
Professor Joe Lyding has recently developed a new method for sharpening probes for Scan Probe Microscopes. Using ions to sharpen the tip to an atomic level, the ultrasharp probes allow...
Click here for more information.
CHAMPAIGN, Ill. — A simple new improvement to an essential microscope component could greatly improve imaging for researchers who study the very small, from cells to computer chips.
Joseph Lyding, a professor of electrical and computer engineering ...
2012-07-07
Rainfall and temperature affect the abundance of two mosquito species linked to West Nile Virus in storm catch basins in suburban Chicago, two University of Illinois researchers report.
Marilyn O'Hara Ruiz, a professor of pathobiology, led the study with graduate student Allison Gardner.
The study was conducted using mosquito larvae collected from catch basins in Alsip, a southwest suburb. The researchers examined weather factors that influenced the levels of mosquito larvae in the basins. They found that low rainfall and high temperatures are associated with high numbers ...
2012-07-07
BUFFALO, N.Y. -- University at Buffalo physicists are among researchers engaged in one of modern history's most exciting scientific endeavors: The hunt for the elusive Higgs boson, a subatomic particle that could help explain why objects have mass.
The particle is the last particle in the Standard Model of particle physics that scientists have yet to observe conclusively. If discovered, the Higgs boson would help validate the model, which describes how particles and forces interact with one another. The model enables physicists to describe how the world around us works.
On ...
2012-07-07
Athens, Ga. – Children need quality physical education to combat obesity and lead healthy lives. Georgia elementary schools make the grade when it comes to providing that education, but middle and high schools in the state don't even come close, according to a University of Georgia study.
A study by UGA kinesiology professor Bryan McCullick examined the mandates for school-based physical education in all 50 United States. The results found only six states mandate the appropriate guidelines—150 minutes each week—for elementary school physical education. For older students, ...
2012-07-07
Dr Changfa Guo, Professor Chunsheng Wang and their co-investigators from Zhongshan hospital Fudan University, Shanghai, China have established a novel hyperbranched poly(amidoamine) (hPAMAM) nanoparticle based hypoxia regulated vascular endothelial growth factor (HRE-VEGF) gene therapy strategy which is an excellent substitute for the current expensive and uncontrollable VEGF gene delivery system. This discovery, reported in the June 2012 issue of Experimental Biology and Medicine, provides an economical, feasible and biocompatible gene therapy strategy for cardiac repair.
Transplantation ...
2012-07-07
Patients look up their illnesses online to become better informed and prepared to play an active role in their care — not because they mistrust their doctors, a new University of California, Davis, study suggests.
The study surveyed more than 500 people who were members of online support groups and had scheduled appointments with a physician.
"We found that mistrust was not a significant predictor of people going online for health information prior to their visit," said Xinyi Hu, who co-authored the study as part of her master's thesis in communication. "This was somewhat ...
2012-07-07
AMHERST, Mass. – Physicists Benjamin Brau, Carlo Dallapiccola and Stephane Willocq at the University of Massachusetts Amherst were instrumental in this week's preliminary observation of a new particle, possibly the long-sought Higgs boson, announced by the European Organization for Nuclear Research (CERN) particle physics laboratory.
The Standard Model of particle physics can correctly explain the elementary particles and forces of nature after more than four decades of experiments. But it cannot, without the Higgs boson, explain how most of these particles acquire their ...
LAST 30 PRESS RELEASES:
[Press-News.org] BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa
